Company / Operating Income
PROCEPT BioRobotics Corp Operating Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$103.9M
FY2025
5-year range
-$109.2M / -$47.8M
FY2021-FY2025
Trend
-7.5%
vs FY2024
Sector context
#133 of 156
Health Care
What the data says
PROCEPT BioRobotics Corp's operating income of -$104M is lower than 85% of companies in the Health Care sector (FY2025). Improved from -$109M to -$104M over the past 2 years.
Based on SEC 10-K filings.
-$104M in FY2025.
Improved from -$109M to -$104M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 156This company -$103.9M Sector average $733.1M
▼
-114.2% below sector average
Key checks
Key Insights
- In FY2025, operating income decreased 7.5% year-over-year.
- Ranks #133 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2021.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$103.9M | -7.5% |
| FY2024 | -$96.6M | +11.5% |
| FY2023 | -$109.2M | -101.6% |
| FY2022 | -$54.2M | -13.3% |
| FY2021 | -$47.8M | +0.0% |
| FY2020 | -$47.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026